Peter Anderson, MD, Pediatric Hematology Oncology and Blood and Marrow Transplantation of Cleveland Clinic discusses moving ONC201 from Phase 2 to Phase 3 and how they need to Establish Better Quality of Life, Better Tumor Markers and that May Lead to Fastrack.
ONC201 Moving to Phase III Establish Better Quality of Life & Tumor Markers May Lead to Fastrack
